SCHEMBL3784748

SCHEMBL3784748

CCNc1cc(B(O)O)ccc1N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ GFER P55789 1/20 0.42
▸ PLEC Q15149 1/20 0.42
▸ LPL P06858 9/20 0.40
▸ LIPG Q9Y5X9 9/20 0.40
▸ ENPP2 Q13822 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ RECQL P46063 1/20 0.37
▸ CA2 P00918 3/20 0.34
▸ CA1 P00915 2/20 0.34
▸ F11 P03951 1/20 0.33
▸ IDO1 P14902 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3790364 0.86 KDM4E (0.54) LMNAKDM4EALDH1A1GAAMAPT
SCHEMBL3785827 0.83 LPL (0.44) KDM4EALDH1A1GAAMAPTTHRB
SCHEMBL3783983 0.79 ENPP2 (0.41) KDM4EALDH1A1LPLLIPGENPP2
SCHEMBL24873925 0.79 AOC1 (0.45) KDM4EALDH1A1GAAMAPTTHRB
SCHEMBL14341767 0.76 CYP3A4 (0.63) LMNAKDM4EALDH1A1GAAMAPT
SCHEMBL22112765 0.75 LMNA (0.51) LMNAKDM4EALDH1A1GAAMAPT
SCHEMBL8522276 0.75 LMNA (0.51) LMNAKDM4EALDH1A1GAAMAPT
Hydrochloric Acid SCHEMBL6852075 0.73 LMNA (0.50) LMNAKDM4EALDH1A1GAAMAPT
SCHEMBL2014730 0.73 LMNA (0.50) LMNAKDM4EALDH1A1GAAMAPT
SCHEMBL3785016 0.73 LPL (0.50) KDM4EALDH1A1LPLLIPGENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 — — US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 LMNA 3250/4885KDM4E 2606/4885ALDH1A1 4339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback